PKCPY yields 2.72% · JNJ yields 2.13%● Live data
📍 PKCPY pulled ahead of the other in Year 1
Combined, PKCPY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PKCPY + JNJ for your $10,000?
PT AKR Corporindo Tbk, a logistics and supply chain company, engages in distribution and trading of petroleum and basic chemical products primarily in Indonesia. It operates through four segments: Trading and Distribution, Logistics Services, Manufacturing, and Industrial Estate. The Trading and Distribution segment is involved in the distribution of petroleum products and various basic chemicals, such as caustic soda, sodium sulphate, PVC resins, and soda ash. The Logistics Services segment offers various logistics services, including rental of storage tanks and warehouses, bagging, port handling, and transportation services primarily for liquid and solid chemical, and petroleum products. The Manufacturing segment produces and sells adhesive materials. The Industrial Estate segment leases and sells industrial and port estates. The company was formerly known as PT Aneka Kimia Raya Tbk and changed its name to PT AKR Corporindo Tbk in September 2004. The company was incorporated in 1977 and is headquartered in Jakarta, Indonesia. PT AKR Corporindo Tbk is a subsidiary of PT Arthakencana Rayatama.
Full PKCPY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.